Gamgee raises $4.0M Seed (Australia, Aug 2026)
Reach the investors backing rounds like this
Backed by Founders Fund, Y Combinator · verified emails and LinkedIn on Datapile
AI-powered dog cancer vaccine startup Gamgee secures $4M in seed funding - KuCoin
Gamgee is a startup focused on developing AI-powered personalized cancer vaccines for dogs. Founded by Paul Conyngham, the company aims to leverage advanced technology to create scalable treatments for canine cancer, addressing a significant gap in veterinary medicine. The recent $4 million seed funding will help accelerate their clinical trials and product development.
AI-powered dog cancer vaccine startup Gamgee secures $4M in seed funding KuCoin
| Aug 19, 2026 | Nbryo | $20.0M | — | Australia |
| Aug 19, 2026 | Nybro | $20.0M | Seed | Australia |
| Aug 16, 2026 | Everlab | $65.0M | Series A | Australia |
| Aug 16, 2026 | Cooee Native Superfoods | $1.5M | Series A | Australia |
14,003 investors back startups in Australia
You just read who funded Gamgee. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 5 investor contact unlocks a month, no card required.